Strontium Citrate (CAS NO : 813-97-8)

Strontium Citrate (CAS 40182-75-0) has emerged as a critical component in the US API intermediates market, particularly for high-purity bone health formulations where a Pharma/API purity of 99% is mandatory to ensure patient safety and therapeutic efficacy. Distrontium Tricitrate is increasingly integrated into domestic CDMO growth strategies, as US-based manufacturers seek custom synthesis services to develop specialized orthopedic therapeutics while maintaining rigorous regulatory compliance and supply chain transparency. Strontium(II) Citrate serves as a high purity fine chemical essential for advanced mineral active research, prompting every leading bulk chemical supplier to provide exhaustive documentation and analytical validation (HPLC/NMR/MS) to meet the evolving standards of the American chemical society. We are an established Strontium Citrate intermediates supplier with >= 99% purity in the united states, ensuring minimal carry-over of impurities in the final API, and a broad range of various pharmaceutical intermediates for API manufacturers and finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting Strontium Citrate COA/TDS/SDS region-specific regulatory support. reliable lead times, worldwide supply chain capabilities